289 related articles for article (PubMed ID: 24915637)
1. Delivery strategies for sustained drug release in the lungs.
Loira-Pastoriza C; Todoroff J; Vanbever R
Adv Drug Deliv Rev; 2014 Aug; 75():81-91. PubMed ID: 24915637
[TBL] [Abstract][Full Text] [Related]
2. Sustained-release from nanocarriers: a review.
Natarajan JV; Nugraha C; Ng XW; Venkatraman S
J Control Release; 2014 Nov; 193():122-38. PubMed ID: 24862321
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary liposomal formulations encapsulated procaterol hydrochloride by a remote loading method achieve sustained release and extended pharmacological effects.
Tahara K; Tomida H; Ito Y; Tachikawa S; Onodera R; Tanaka H; Tozuka Y; Takeuchi H
Int J Pharm; 2016 May; 505(1-2):139-46. PubMed ID: 27012982
[TBL] [Abstract][Full Text] [Related]
4. Nano-liposomal dry powder inhaler of Amiloride Hydrochloride.
Chougule MB; Padhi BK; Misra A
J Nanosci Nanotechnol; 2006; 6(9-10):3001-9. PubMed ID: 17048511
[TBL] [Abstract][Full Text] [Related]
5. Swellable microparticles as carriers for sustained pulmonary drug delivery.
El-Sherbiny IM; McGill S; Smyth HD
J Pharm Sci; 2010 May; 99(5):2343-56. PubMed ID: 19967777
[TBL] [Abstract][Full Text] [Related]
6. Polyethylene glycol-drug ester conjugates for prolonged retention of small inhaled drugs in the lung.
Bayard FJ; Thielemans W; Pritchard DI; Paine SW; Young SS; Bäckman P; Ewing P; Bosquillon C
J Control Release; 2013 Oct; 171(2):234-40. PubMed ID: 23916883
[TBL] [Abstract][Full Text] [Related]
7. Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung.
Wanakule P; Liu GW; Fleury AT; Roy K
J Control Release; 2012 Sep; 162(2):429-37. PubMed ID: 22841795
[TBL] [Abstract][Full Text] [Related]
8. Sustained therapeutic efficacy of budesonide-loaded chitosan swellable microparticles after lung delivery: Influence of in vitro release, treatment interval and dose.
Zhang L; Yang L; Zhang X; Jiaqi L; Fan L; Beck-Broichsitter M; Zhang X; Muenster U; Wang X; Zhao J; Zhang Y; Mao S
J Control Release; 2018 Aug; 283():163-174. PubMed ID: 29842919
[TBL] [Abstract][Full Text] [Related]
9. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
Patel B; Gupta V; Ahsan F
J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based carriers for pulmonary products: preclinical development and case studies in humans.
Cipolla D; Shekunov B; Blanchard J; Hickey A
Adv Drug Deliv Rev; 2014 Aug; 75():53-80. PubMed ID: 24819218
[TBL] [Abstract][Full Text] [Related]
11. Inhaled extended-release microparticles of heparin elicit improved pulmonary pharmacodynamics against antigen-mediated airway hyper-reactivity and inflammation.
Yildiz A; John E; Özsoy Y; Araman A; Birchall JC; Broadley KJ; Gumbleton M
J Control Release; 2012 Sep; 162(2):456-63. PubMed ID: 22800577
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
Gill KK; Nazzal S; Kaddoumi A
Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in controlled pulmonary drug delivery.
Liang Z; Ni R; Zhou J; Mao S
Drug Discov Today; 2015 Mar; 20(3):380-9. PubMed ID: 25281854
[TBL] [Abstract][Full Text] [Related]
14. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats.
Karathanasis E; Bhavane R; Annapragada AV
J Control Release; 2006 Jun; 113(2):117-27. PubMed ID: 16765471
[TBL] [Abstract][Full Text] [Related]
15. Novel sustained release microspheres for pulmonary drug delivery.
Cook RO; Pannu RK; Kellaway IW
J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
[TBL] [Abstract][Full Text] [Related]
16. Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system.
Liu J; Jiang Y; Cui Y; Xu C; Ji X; Luan Y
Int J Pharm; 2014 Oct; 473(1-2):560-71. PubMed ID: 25066076
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary sustained release of insulin from microparticles composed of polyelectrolyte layer-by-layer assembly.
Amancha KP; Balkundi S; Lvov Y; Hussain A
Int J Pharm; 2014 May; 466(1-2):96-108. PubMed ID: 24566038
[TBL] [Abstract][Full Text] [Related]
18. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
Ngan CL; Asmawi AA
Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
[TBL] [Abstract][Full Text] [Related]
19. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
20. Sustained release drug delivery to the lungs: an option for the future.
Hardy JG; Chadwick TS
Clin Pharmacokinet; 2000 Jul; 39(1):1-4. PubMed ID: 10926347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
